Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • rainbow over text: 'thank you NHS'
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Eco Animal Health gets positive opinion from EMA on Aivlosin use

Fri 22 May 2020 16:03 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Eco Animal Health Group announced on Friday that it has received a positive opinion from the European Medicines Agency (EMA) for the use of 'Aivlosin' 625 mg/g water soluble granules for the treatment and metaphylaxis of mycoplasma hyopneumoniae in pigs.

The AIM-traded firm explained that mycoplasma hyopneumoniae is "the most common" primary pathogen in pig respiratory disease, and is a "key instigator" of secondary bacterial and viral pathogens.

It said its patented antimicrobial, Aivlosin, is used under veterinary prescription for the treatment of a variety of "economically important" respiratory and enteric diseases in poultry and pigs.

The European Commission was expected to issue a marketing authorisation within two months of the publication of a positive opinion, the board said.

"Aivlosin offers a safe and highly effective medication for Mycoplasma infections," said chief executive officer Marc Loomes.

"This positive opinion is significant, not only in the European Union, which has 15% of the world's pigs, but for other large international swine markets as this indication is rolled out.

"Whilst we bring forward our new product development programme, particularly around vaccines, it is important to note that Aivlosin's approved usage continues to expand across multiple treatment areas and markets."

At 1548 BST, shares in Eco Animal Health Group were up 5.32% at 208p.

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.

    More AIM news from ShareCast

    No results were found